whispers in the corridors
Revance Therapeutics announces executive changes
Revance Therapeutics announced executive changes effective October 1, 2025: Kira Schwartz joined as Chief Legal Officer, bringing 20+ years from biotech firms; Nick Crowe was promoted from VP to Chief Operating Officer, overseeing global operations. These aim to streamline regulatory and supply chain functions amid product launches.
Send Feedback
More Corporate News
- S Varadarajan steps down as Director, Indsil Hydro Power and Manganese Ltd
- K Ramakrishnan quits as Director, Indsil Hydro Power and Manganese Ltd
- Ms Anu Murali appointed Addl. Director, Indsil Hydro Power and Manganese Ltd
- Rudra Narsiman appointed Addl. Director, Indsil Hydro Power and Manganese Ltd
- Vishwaa Narasiman appointed Addl. Director, Indsil Hydro Power and Manganese Ltd
- Subbiah Thangaraj appointed Whole-Time Director, Indsil Hydro Power and Manganese Ltd
- Parimal Rai appointed Addl. Director, Jindal Steel Ltd
- Ms Anjali Gupte appointed NE Director, Astec Lifesciences Ltd
- Nandkumar Dhekne appointed NE Director, Astec Lifesciences Ltd
- RS Bhat appointed MD & CEO, Karnataka Bank Ltd
- Sanjay Jain appointed Chairman, Enviro Infra Engineers Ltd
- Venkanna Konda appointed MD, Raasi Refractories Ltd
- FB Financial Corporation realignes senior roles
- Airbus announces $2 Bn sourcing from India
